Global Amlodipine and Olmesartan Market Insights, Forecast to 2028

Global Amlodipine and Olmesartan Market Insights, Forecast to 2028

Table of Contents
1 Study Coverage
1.1 Amlodipine and Olmesartan Product Introduction
1.2 Market by Type
1.2.1 Global Amlodipine and Olmesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 5/20 mg Tablets
1.2.3 10/20 mg Tablets
1.2.4 5/40 mg Tablets
1.2.5 10/40 mg Tablets
1.3 Market by Application
1.3.1 Global Amlodipine and Olmesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Drug store
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Amlodipine and Olmesartan Sales Estimates and Forecasts 2017-2028
2.2 Global Amlodipine and Olmesartan Revenue Estimates and Forecasts 2017-2028
2.3 Global Amlodipine and Olmesartan Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Amlodipine and Olmesartan Sales by Region
2.4.1 Global Amlodipine and Olmesartan Sales by Region (2017-2022)
2.4.2 Global Sales Amlodipine and Olmesartan by Region (2023-2028)
2.5 Global Amlodipine and Olmesartan Revenue by Region
2.5.1 Global Amlodipine and Olmesartan Revenue by Region (2017-2022)
2.5.2 Global Amlodipine and Olmesartan Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Amlodipine and Olmesartan Sales by Manufacturers
3.1.1 Global Top Amlodipine and Olmesartan Manufacturers by Sales (2017-2022)
3.1.2 Global Amlodipine and Olmesartan Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Amlodipine and Olmesartan in 2021
3.2 Global Amlodipine and Olmesartan Revenue by Manufacturers
3.2.1 Global Amlodipine and Olmesartan Revenue by Manufacturers (2017-2022)
3.2.2 Global Amlodipine and Olmesartan Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Amlodipine and Olmesartan Revenue in 2021
3.3 Global Amlodipine and Olmesartan Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Amlodipine and Olmesartan Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Amlodipine and Olmesartan Sales by Type
4.1.1 Global Amlodipine and Olmesartan Historical Sales by Type (2017-2022)
4.1.2 Global Amlodipine and Olmesartan Forecasted Sales by Type (2023-2028)
4.1.3 Global Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
4.2 Global Amlodipine and Olmesartan Revenue by Type
4.2.1 Global Amlodipine and Olmesartan Historical Revenue by Type (2017-2022)
4.2.2 Global Amlodipine and Olmesartan Forecasted Revenue by Type (2023-2028)
4.2.3 Global Amlodipine and Olmesartan Revenue Market Share by Type (2017-2028)
4.3 Global Amlodipine and Olmesartan Price by Type
4.3.1 Global Amlodipine and Olmesartan Price by Type (2017-2022)
4.3.2 Global Amlodipine and Olmesartan Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Amlodipine and Olmesartan Sales by Application
5.1.1 Global Amlodipine and Olmesartan Historical Sales by Application (2017-2022)
5.1.2 Global Amlodipine and Olmesartan Forecasted Sales by Application (2023-2028)
5.1.3 Global Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
5.2 Global Amlodipine and Olmesartan Revenue by Application
5.2.1 Global Amlodipine and Olmesartan Historical Revenue by Application (2017-2022)
5.2.2 Global Amlodipine and Olmesartan Forecasted Revenue by Application (2023-2028)
5.2.3 Global Amlodipine and Olmesartan Revenue Market Share by Application (2017-2028)
5.3 Global Amlodipine and Olmesartan Price by Application
5.3.1 Global Amlodipine and Olmesartan Price by Application (2017-2022)
5.3.2 Global Amlodipine and Olmesartan Price Forecast by Application (2023-2028)
6 North America
6.1 North America Amlodipine and Olmesartan Market Size by Type
6.1.1 North America Amlodipine and Olmesartan Sales by Type (2017-2028)
6.1.2 North America Amlodipine and Olmesartan Revenue by Type (2017-2028)
6.2 North America Amlodipine and Olmesartan Market Size by Application
6.2.1 North America Amlodipine and Olmesartan Sales by Application (2017-2028)
6.2.2 North America Amlodipine and Olmesartan Revenue by Application (2017-2028)
6.3 North America Amlodipine and Olmesartan Market Size by Country
6.3.1 North America Amlodipine and Olmesartan Sales by Country (2017-2028)
6.3.2 North America Amlodipine and Olmesartan Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Amlodipine and Olmesartan Market Size by Type
7.1.1 Europe Amlodipine and Olmesartan Sales by Type (2017-2028)
7.1.2 Europe Amlodipine and Olmesartan Revenue by Type (2017-2028)
7.2 Europe Amlodipine and Olmesartan Market Size by Application
7.2.1 Europe Amlodipine and Olmesartan Sales by Application (2017-2028)
7.2.2 Europe Amlodipine and Olmesartan Revenue by Application (2017-2028)
7.3 Europe Amlodipine and Olmesartan Market Size by Country
7.3.1 Europe Amlodipine and Olmesartan Sales by Country (2017-2028)
7.3.2 Europe Amlodipine and Olmesartan Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Amlodipine and Olmesartan Market Size by Type
8.1.1 Asia Pacific Amlodipine and Olmesartan Sales by Type (2017-2028)
8.1.2 Asia Pacific Amlodipine and Olmesartan Revenue by Type (2017-2028)
8.2 Asia Pacific Amlodipine and Olmesartan Market Size by Application
8.2.1 Asia Pacific Amlodipine and Olmesartan Sales by Application (2017-2028)
8.2.2 Asia Pacific Amlodipine and Olmesartan Revenue by Application (2017-2028)
8.3 Asia Pacific Amlodipine and Olmesartan Market Size by Region
8.3.1 Asia Pacific Amlodipine and Olmesartan Sales by Region (2017-2028)
8.3.2 Asia Pacific Amlodipine and Olmesartan Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Amlodipine and Olmesartan Market Size by Type
9.1.1 Latin America Amlodipine and Olmesartan Sales by Type (2017-2028)
9.1.2 Latin America Amlodipine and Olmesartan Revenue by Type (2017-2028)
9.2 Latin America Amlodipine and Olmesartan Market Size by Application
9.2.1 Latin America Amlodipine and Olmesartan Sales by Application (2017-2028)
9.2.2 Latin America Amlodipine and Olmesartan Revenue by Application (2017-2028)
9.3 Latin America Amlodipine and Olmesartan Market Size by Country
9.3.1 Latin America Amlodipine and Olmesartan Sales by Country (2017-2028)
9.3.2 Latin America Amlodipine and Olmesartan Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Amlodipine and Olmesartan Market Size by Type
10.1.1 Middle East and Africa Amlodipine and Olmesartan Sales by Type (2017-2028)
10.1.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Type (2017-2028)
10.2 Middle East and Africa Amlodipine and Olmesartan Market Size by Application
10.2.1 Middle East and Africa Amlodipine and Olmesartan Sales by Application (2017-2028)
10.2.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2017-2028)
10.3 Middle East and Africa Amlodipine and Olmesartan Market Size by Country
10.3.1 Middle East and Africa Amlodipine and Olmesartan Sales by Country (2017-2028)
10.3.2 Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Daiichi Sankyo
11.1.1 Daiichi Sankyo Corporation Information
11.1.2 Daiichi Sankyo Overview
11.1.3 Daiichi Sankyo Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Daiichi Sankyo Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Daiichi Sankyo Recent Developments
11.2 Teva
11.2.1 Teva Corporation Information
11.2.2 Teva Overview
11.2.3 Teva Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Teva Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Teva Recent Developments
11.3 Glenmark Pharmaceuticals
11.3.1 Glenmark Pharmaceuticals Corporation Information
11.3.2 Glenmark Pharmaceuticals Overview
11.3.3 Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Glenmark Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Glenmark Pharmaceuticals Recent Developments
11.4 Matrix Laboratories
11.4.1 Matrix Laboratories Corporation Information
11.4.2 Matrix Laboratories Overview
11.4.3 Matrix Laboratories Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Matrix Laboratories Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Matrix Laboratories Recent Developments
11.5 Torrent Pharmaceuticals
11.5.1 Torrent Pharmaceuticals Corporation Information
11.5.2 Torrent Pharmaceuticals Overview
11.5.3 Torrent Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Torrent Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Torrent Pharmaceuticals Recent Developments
11.6 Aurobindo
11.6.1 Aurobindo Corporation Information
11.6.2 Aurobindo Overview
11.6.3 Aurobindo Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Aurobindo Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Aurobindo Recent Developments
11.7 Macleods Pharmaceuticals
11.7.1 Macleods Pharmaceuticals Corporation Information
11.7.2 Macleods Pharmaceuticals Overview
11.7.3 Macleods Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Macleods Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Macleods Pharmaceuticals Recent Developments
11.8 Alembic Pharmaceuticals
11.8.1 Alembic Pharmaceuticals Corporation Information
11.8.2 Alembic Pharmaceuticals Overview
11.8.3 Alembic Pharmaceuticals Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Alembic Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Alembic Pharmaceuticals Recent Developments
11.9 Ajanta Pharma
11.9.1 Ajanta Pharma Corporation Information
11.9.2 Ajanta Pharma Overview
11.9.3 Ajanta Pharma Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Ajanta Pharma Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Ajanta Pharma Recent Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Corporation Information
11.10.2 Jubilant Pharma Overview
11.10.3 Jubilant Pharma Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jubilant Pharma Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jubilant Pharma Recent Developments
11.11 Accord Healthcare
11.11.1 Accord Healthcare Corporation Information
11.11.2 Accord Healthcare Overview
11.11.3 Accord Healthcare Amlodipine and Olmesartan Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Accord Healthcare Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Accord Healthcare Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Amlodipine and Olmesartan Industry Chain Analysis
12.2 Amlodipine and Olmesartan Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Amlodipine and Olmesartan Production Mode & Process
12.4 Amlodipine and Olmesartan Sales and Marketing
12.4.1 Amlodipine and Olmesartan Sales Channels
12.4.2 Amlodipine and Olmesartan Distributors
12.5 Amlodipine and Olmesartan Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Amlodipine and Olmesartan Industry Trends
13.2 Amlodipine and Olmesartan Market Drivers
13.3 Amlodipine and Olmesartan Market Challenges
13.4 Amlodipine and Olmesartan Market Restraints
14 Key Findings in The Global Amlodipine and Olmesartan Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Amlodipine and Olmesartan Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of 5/20 mg Tablets
Table 3. Major Manufacturers of 10/20 mg Tablets
Table 4. Major Manufacturers of 5/40 mg Tablets
Table 5. Major Manufacturers of 10/40 mg Tablets
Table 6. Global Amlodipine and Olmesartan Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 7. Global Amlodipine and Olmesartan Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Amlodipine and Olmesartan Sales by Region (2017-2022) & (K Units)
Table 9. Global Amlodipine and Olmesartan Sales Market Share by Region (2017-2022)
Table 10. Global Amlodipine and Olmesartan Sales by Region (2023-2028) & (K Units)
Table 11. Global Amlodipine and Olmesartan Sales Market Share by Region (2023-2028)
Table 12. Global Amlodipine and Olmesartan Revenue by Region (2017-2022) & (US$ Million)
Table 13. Global Amlodipine and Olmesartan Revenue Market Share by Region (2017-2022)
Table 14. Global Amlodipine and Olmesartan Revenue by Region (2023-2028) & (US$ Million)
Table 15. Global Amlodipine and Olmesartan Revenue Market Share by Region (2023-2028)
Table 16. Global Amlodipine and Olmesartan Sales by Manufacturers (2017-2022) & (K Units)
Table 17. Global Amlodipine and Olmesartan Sales Share by Manufacturers (2017-2022)
Table 18. Global Amlodipine and Olmesartan Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 19. Global Amlodipine and Olmesartan Revenue Share by Manufacturers (2017-2022)
Table 20. Amlodipine and Olmesartan Price by Manufacturers (2017-2022) &(USD/Unit)
Table 21. Global Amlodipine and Olmesartan Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Amlodipine and Olmesartan by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amlodipine and Olmesartan as of 2021)
Table 23. Amlodipine and Olmesartan Manufacturing Base Distribution and Headquarters
Table 24. Manufacturers Amlodipine and Olmesartan Product Offered
Table 25. Date of Manufacturers Enter into Amlodipine and Olmesartan Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 28. Global Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 29. Global Amlodipine and Olmesartan Sales Share by Type (2017-2022)
Table 30. Global Amlodipine and Olmesartan Sales Share by Type (2023-2028)
Table 31. Global Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 32. Global Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 33. Global Amlodipine and Olmesartan Revenue Share by Type (2017-2022)
Table 34. Global Amlodipine and Olmesartan Revenue Share by Type (2023-2028)
Table 35. Amlodipine and Olmesartan Price by Type (2017-2022) & (USD/Unit)
Table 36. Global Amlodipine and Olmesartan Price Forecast by Type (2023-2028) & (USD/Unit)
Table 37. Global Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 38. Global Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 39. Global Amlodipine and Olmesartan Sales Share by Application (2017-2022)
Table 40. Global Amlodipine and Olmesartan Sales Share by Application (2023-2028)
Table 41. Global Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 42. Global Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 43. Global Amlodipine and Olmesartan Revenue Share by Application (2017-2022)
Table 44. Global Amlodipine and Olmesartan Revenue Share by Application (2023-2028)
Table 45. Amlodipine and Olmesartan Price by Application (2017-2022) & (USD/Unit)
Table 46. Global Amlodipine and Olmesartan Price Forecast by Application (2023-2028) & (USD/Unit)
Table 47. North America Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 48. North America Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 49. North America Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 50. North America Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 51. North America Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 52. North America Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 53. North America Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 54. North America Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 55. North America Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 56. North America Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 57. North America Amlodipine and Olmesartan Revenue by Country (2017-2022) & (US$ Million)
Table 58. North America Amlodipine and Olmesartan Revenue by Country (2023-2028) & (US$ Million)
Table 59. Europe Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 60. Europe Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 61. Europe Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 62. Europe Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 63. Europe Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 64. Europe Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 65. Europe Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 66. Europe Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 67. Europe Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 68. Europe Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 69. Europe Amlodipine and Olmesartan Revenue by Country (2017-2022) & (US$ Million)
Table 70. Europe Amlodipine and Olmesartan Revenue by Country (2023-2028) & (US$ Million)
Table 71. Asia Pacific Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 72. Asia Pacific Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 73. Asia Pacific Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 74. Asia Pacific Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 75. Asia Pacific Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 76. Asia Pacific Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 77. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 78. Asia Pacific Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 79. Asia Pacific Amlodipine and Olmesartan Sales by Region (2017-2022) & (K Units)
Table 80. Asia Pacific Amlodipine and Olmesartan Sales by Region (2023-2028) & (K Units)
Table 81. Asia Pacific Amlodipine and Olmesartan Revenue by Region (2017-2022) & (US$ Million)
Table 82. Asia Pacific Amlodipine and Olmesartan Revenue by Region (2023-2028) & (US$ Million)
Table 83. Latin America Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 84. Latin America Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 85. Latin America Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 86. Latin America Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 87. Latin America Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 88. Latin America Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 89. Latin America Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 90. Latin America Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 91. Latin America Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 92. Latin America Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 93. Latin America Amlodipine and Olmesartan Revenue by Country (2017-2022) & (US$ Million)
Table 94. Latin America Amlodipine and Olmesartan Revenue by Country (2023-2028) & (US$ Million)
Table 95. Middle East and Africa Amlodipine and Olmesartan Sales by Type (2017-2022) & (K Units)
Table 96. Middle East and Africa Amlodipine and Olmesartan Sales by Type (2023-2028) & (K Units)
Table 97. Middle East and Africa Amlodipine and Olmesartan Revenue by Type (2017-2022) & (US$ Million)
Table 98. Middle East and Africa Amlodipine and Olmesartan Revenue by Type (2023-2028) & (US$ Million)
Table 99. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2017-2022) & (K Units)
Table 100. Middle East and Africa Amlodipine and Olmesartan Sales by Application (2023-2028) & (K Units)
Table 101. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2017-2022) & (US$ Million)
Table 102. Middle East and Africa Amlodipine and Olmesartan Revenue by Application (2023-2028) & (US$ Million)
Table 103. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2017-2022) & (K Units)
Table 104. Middle East and Africa Amlodipine and Olmesartan Sales by Country (2023-2028) & (K Units)
Table 105. Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2017-2022) & (US$ Million)
Table 106. Middle East and Africa Amlodipine and Olmesartan Revenue by Country (2023-2028) & (US$ Million)
Table 107. Daiichi Sankyo Corporation Information
Table 108. Daiichi Sankyo Description and Major Businesses
Table 109. Daiichi Sankyo Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 110. Daiichi Sankyo Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Daiichi Sankyo Recent Developments
Table 112. Teva Corporation Information
Table 113. Teva Description and Major Businesses
Table 114. Teva Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 115. Teva Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. Teva Recent Developments
Table 117. Glenmark Pharmaceuticals Corporation Information
Table 118. Glenmark Pharmaceuticals Description and Major Businesses
Table 119. Glenmark Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 120. Glenmark Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Glenmark Pharmaceuticals Recent Developments
Table 122. Matrix Laboratories Corporation Information
Table 123. Matrix Laboratories Description and Major Businesses
Table 124. Matrix Laboratories Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 125. Matrix Laboratories Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Matrix Laboratories Recent Developments
Table 127. Torrent Pharmaceuticals Corporation Information
Table 128. Torrent Pharmaceuticals Description and Major Businesses
Table 129. Torrent Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 130. Torrent Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Torrent Pharmaceuticals Recent Developments
Table 132. Aurobindo Corporation Information
Table 133. Aurobindo Description and Major Businesses
Table 134. Aurobindo Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 135. Aurobindo Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. Aurobindo Recent Developments
Table 137. Macleods Pharmaceuticals Corporation Information
Table 138. Macleods Pharmaceuticals Description and Major Businesses
Table 139. Macleods Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 140. Macleods Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. Macleods Pharmaceuticals Recent Developments
Table 142. Alembic Pharmaceuticals Corporation Information
Table 143. Alembic Pharmaceuticals Description and Major Businesses
Table 144. Alembic Pharmaceuticals Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 145. Alembic Pharmaceuticals Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Alembic Pharmaceuticals Recent Developments
Table 147. Ajanta Pharma Corporation Information
Table 148. Ajanta Pharma Description and Major Businesses
Table 149. Ajanta Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 150. Ajanta Pharma Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. Ajanta Pharma Recent Developments
Table 152. Jubilant Pharma Corporation Information
Table 153. Jubilant Pharma Description and Major Businesses
Table 154. Jubilant Pharma Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 155. Jubilant Pharma Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Jubilant Pharma Recent Developments
Table 157. Accord Healthcare Corporation Information
Table 158. Accord Healthcare Description and Major Businesses
Table 159. Accord Healthcare Amlodipine and Olmesartan Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
Table 160. Accord Healthcare Amlodipine and Olmesartan Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Accord Healthcare Recent Developments
Table 162. Key Raw Materials Lists
Table 163. Raw Materials Key Suppliers Lists
Table 164. Amlodipine and Olmesartan Distributors List
Table 165. Amlodipine and Olmesartan Customers List
Table 166. Amlodipine and Olmesartan Market Trends
Table 167. Amlodipine and Olmesartan Market Drivers
Table 168. Amlodipine and Olmesartan Market Challenges
Table 169. Amlodipine and Olmesartan Market Restraints
Table 170. Research Programs/Design for This Report
Table 171. Key Data Information from Secondary Sources
Table 172. Key Data Information from Primary Sources
List of Figures
Figure 1. Amlodipine and Olmesartan Product Picture
Figure 3. Global Amlodipine and Olmesartan Market Share by Type in 2021 & 2028
Figure 3. 5/20 mg Tablets Product Picture
Figure 4. 10/20 mg Tablets Product Picture
Figure 5. 5/40 mg Tablets Product Picture
Figure 6. 10/40 mg Tablets Product Picture
Figure 7. Global Amlodipine and Olmesartan Market Share by Application in 2021 & 2028
Figure 8. Hospital
Figure 9. Drug store
Figure 10. Amlodipine and Olmesartan Report Years Considered
Figure 11. Global Amlodipine and Olmesartan Sales 2017-2028 (K Units)
Figure 12. Global Amlodipine and Olmesartan Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 13. Global Amlodipine and Olmesartan Revenue 2017-2028 (US$ Million)
Figure 14. Global Amlodipine and Olmesartan Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 15. Global Amlodipine and Olmesartan Sales Market Share by Region (2017-2022)
Figure 16. Global Amlodipine and Olmesartan Sales Market Share by Region (2023-2028)
Figure 17. North America Amlodipine and Olmesartan Sales YoY (2017-2028) & (K Units)
Figure 18. North America Amlodipine and Olmesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 19. Europe Amlodipine and Olmesartan Sales YoY (2017-2028) & (K Units)
Figure 20. Europe Amlodipine and Olmesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Asia-Pacific Amlodipine and Olmesartan Sales YoY (2017-2028) & (K Units)
Figure 22. Asia-Pacific Amlodipine and Olmesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Latin America Amlodipine and Olmesartan Sales YoY (2017-2028) & (K Units)
Figure 24. Latin America Amlodipine and Olmesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Middle East & Africa Amlodipine and Olmesartan Sales YoY (2017-2028) & (K Units)
Figure 26. Middle East & Africa Amlodipine and Olmesartan Revenue YoY (2017-2028) & (US$ Million)
Figure 27. The Amlodipine and Olmesartan Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 28. The Top 5 and 10 Largest Manufacturers of Amlodipine and Olmesartan in the World: Market Share by Amlodipine and Olmesartan Revenue in 2021
Figure 29. Global Amlodipine and Olmesartan Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 30. Global Amlodipine and Olmesartan Sales Market Share by Type (2017-2028)
Figure 31. Global Amlodipine and Olmesartan Revenue Market Share by Type (2017-2028)
Figure 32. Global Amlodipine and Olmesartan Sales Market Share by Application (2017-2028)
Figure 33. Global Amlodipine and Olmesartan Revenue Market Share by Application (2017-2028)
Figure 34. North America Amlodipine and Olme

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs